1. Nat Genet. 2012 Sep;44(9):981-90. doi: 10.1038/ng.2383. Epub 2012 Aug 12.

Large-scale association analysis provides insights into the genetic architecture 
and pathophysiology of type 2 diabetes.

Morris AP(1), Voight BF, Teslovich TM, Ferreira T, Segrè AV, Steinthorsdottir V, 
Strawbridge RJ, Khan H, Grallert H, Mahajan A, Prokopenko I, Kang HM, Dina C, 
Esko T, Fraser RM, Kanoni S, Kumar A, Lagou V, Langenberg C, Luan J, Lindgren 
CM, Müller-Nurasyid M, Pechlivanis S, Rayner NW, Scott LJ, Wiltshire S, Yengo L, 
Kinnunen L, Rossin EJ, Raychaudhuri S, Johnson AD, Dimas AS, Loos RJ, Vedantam 
S, Chen H, Florez JC, Fox C, Liu CT, Rybin D, Couper DJ, Kao WH, Li M, Cornelis 
MC, Kraft P, Sun Q, van Dam RM, Stringham HM, Chines PS, Fischer K, Fontanillas 
P, Holmen OL, Hunt SE, Jackson AU, Kong A, Lawrence R, Meyer J, Perry JR, Platou 
CG, Potter S, Rehnberg E, Robertson N, Sivapalaratnam S, Stančáková A, Stirrups 
K, Thorleifsson G, Tikkanen E, Wood AR, Almgren P, Atalay M, Benediktsson R, 
Bonnycastle LL, Burtt N, Carey J, Charpentier G, Crenshaw AT, Doney AS, Dorkhan 
M, Edkins S, Emilsson V, Eury E, Forsen T, Gertow K, Gigante B, Grant GB, Groves 
CJ, Guiducci C, Herder C, Hreidarsson AB, Hui J, James A, Jonsson A, Rathmann W, 
Klopp N, Kravic J, Krjutškov K, Langford C, Leander K, Lindholm E, Lobbens S, 
Männistö S, Mirza G, Mühleisen TW, Musk B, Parkin M, Rallidis L, Saramies J, 
Sennblad B, Shah S, Sigurðsson G, Silveira A, Steinbach G, Thorand B, Trakalo J, 
Veglia F, Wennauer R, Winckler W, Zabaneh D, Campbell H, van Duijn C, 
Uitterlinden AG, Hofman A, Sijbrands E, Abecasis GR, Owen KR, Zeggini E, Trip 
MD, Forouhi NG, Syvänen AC, Eriksson JG, Peltonen L, Nöthen MM, Balkau B, Palmer 
CN, Lyssenko V, Tuomi T, Isomaa B, Hunter DJ, Qi L; Wellcome Trust Case Control 
Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium 
(MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) 
Consortium; Asian Genetic Epidemiology Network–Type 2 Diabetes (AGEN-T2D) 
Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; Shuldiner AR, Roden 
M, Barroso I, Wilsgaard T, Beilby J, Hovingh K, Price JF, Wilson JF, Rauramaa R, 
Lakka TA, Lind L, Dedoussis G, Njølstad I, Pedersen NL, Khaw KT, Wareham NJ, 
Keinanen-Kiukaanniemi SM, Saaristo TE, Korpi-Hyövälti E, Saltevo J, Laakso M, 
Kuusisto J, Metspalu A, Collins FS, Mohlke KL, Bergman RN, Tuomilehto J, Boehm 
BO, Gieger C, Hveem K, Cauchi S, Froguel P, Baldassarre D, Tremoli E, Humphries 
SE, Saleheen D, Danesh J, Ingelsson E, Ripatti S, Salomaa V, Erbel R, Jöckel KH, 
Moebus S, Peters A, Illig T, de Faire U, Hamsten A, Morris AD, Donnelly PJ, 
Frayling TM, Hattersley AT, Boerwinkle E, Melander O, Kathiresan S, Nilsson PM, 
Deloukas P, Thorsteinsdottir U, Groop LC, Stefansson K, Hu F, Pankow JS, Dupuis 
J, Meigs JB, Altshuler D, Boehnke M, McCarthy MI; DIAbetes Genetics Replication 
And Meta-analysis (DIAGRAM) Consortium.

Author information:
(1)Wellcome Trust Centre for Human Genetics, University of Oxford, UK. 
amorris@well.ox.ac.uk

To extend understanding of the genetic architecture and molecular basis of type 
2 diabetes (T2D), we conducted a meta-analysis of genetic variants on the 
Metabochip, including 34,840 cases and 114,981 controls, overwhelmingly of 
European descent. We identified ten previously unreported T2D susceptibility 
loci, including two showing sex-differentiated association. Genome-wide analyses 
of these data are consistent with a long tail of additional common variant loci 
explaining much of the variation in susceptibility to T2D. Exploration of the 
enlarged set of susceptibility loci implicates several processes, including 
CREBBP-related transcription, adipocytokine signaling and cell cycle regulation, 
in diabetes pathogenesis.

DOI: 10.1038/ng.2383
PMCID: PMC3442244
PMID: 22885922 [Indexed for MEDLINE]